Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?
Details
Publication Year 2011,Volume 13,Issue #3,Page -
Journal Title
BREAST CANCER RESEARCH
Publication Type
Journal Article
Abstract
In vivo transplantation is the current 'gold-standard' assay for evaluating mammary stem cell (MaSC) function. Matrigel, a reconstituted extracellular matrix derived from a mouse sarcoma line, is increasingly being utilized for mammary repopulating assays, although original studies were carried out in its absence. This matrix has also been shown to enhance tumor-initiating capacity. Whilst Matrigel increases the rate of engraftment by MaSCs, it also appears to promote progenitor activity that is distinct from bona fide stem cell activity. This caveat should be considered when interpreting mammary reconstitution assays that incorporate Matrigel, particularly when transplanting high cell numbers.
Publisher
BIOMED CENTRAL LTD
Keywords
EPITHELIAL STEM-CELLS; PROGENITOR CELLS; SELF-RENEWAL; GLAND; RECEPTOR; GROWTH; CANCER; MICE
Publisher's Version
https://doi.org/10.1186/bcr2851
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2011-01-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙